Document:

Employment Agreement

 Exhibit 10.7 
  
 EMPLOYMENT AGREEMENT 
  

This Employment Agreement (“Agreement”) is made and entered into on this 25th day of April, 2003, effective as of April 1, 2003, by and between AMERIPATH, INC., a Delaware corporation (the “Company”), and JEFFREY A.
MOSSLER, M.D. (hereinafter, the “Executive”). 
  
 R E C I T A L S 
  
 A. The Executive is currently employed by AmeriPath Indianaplis, L.L.C., a wholly owned subsidiary of the Company, pursuant to an Employment Agreement dated September 1, 1997, an Amendment to Employment Agreement
dated November 3, 2000, a Memorandum dated February 14, 2001, an Amendment No. 3 to Employment Agreement dated December, 2002 and an Amendment No. 4 to Employment Agreement dated March, 2003 (collectively, the “Prior Employment
Agreement”); and 
  
 B. The Company and the Executive now
wish to enter into this new Agreement, which is intended to supercede and replace the Prior Employment Agreement in its entirety, to reflect the Executive’s position and duties, his compensation, and other terms and conditions of his employment
as Chief Medical Officer of the Company. Upon execution of this Agreement by both the Executive and the Company, the Prior Employment Agreement shall terminate and no longer have any force and effect. 
  
 AGREEMENT 
  
 NOW, THEREFORE, in consideration of the promises and mutual covenants set
forth herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Executive and the Company agree as follows: 
  
 1. Recitals. The foregoing recitals are true and correct and are incorporated herein by this reference. 

 
 2. Employment. 
  
 2.1 Employment and Term. During the Term of
Employment, the Company hereby agrees to employ the Executive and the Executive hereby agrees to serve the Company on the terms and conditions set forth herein. 
  
 2.2 Duties of Executive. During the Term of Employment, the Executive shall serve as the Chief
Medical Officer of the Company, shall report directly to James C. New, the Chairman and CEO of the Company, shall faithfully and diligently perform all services as may be assigned to him by the Board of Directors of the Company (the
“Board”), and shall exercise such power and authority as may from time to time be delegated to him by the Board. The Executive shall devote his full time and attention to the business and affairs of the Company, render such 

  

 - 1 - 

 
services to the best of his ability, and use his reasonable best efforts to promote the interests of the Company. The Executive shall comply with the
Company’s employment policies and practices generally applicable to its officers and employees including, without limitation, insider trading and confidentiality policies. Notwithstanding the foregoing, nothing contained herein is intended to
prohibit the Executive from engaging in the practice of medicine in the course of the Executive’s duties as a member of the U.S. Military, either active or reserve, or the National Guard. The Executive may also (i) engage in personal investment
activities as long as those investments are non-participatory by the Executive; (ii) serve on corporate, civic or charitable boards or committees and participate in community activities; (iii) render consultation services in connection with
litigation matters or give testimony in any action or proceeding as an expert witness, provided such services or testimony does not have an adverse effect on the Company; or (iv) deliver lectures, fulfill speaking engagements or teach at educational
institutions; provided such activities set forth in the preceding clauses (i), (ii), (iii) and (iv) above do not impose additional liability on the Company and do not detract from the Executive’s ability to perform the Executive’s duties
to the Company. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN, NOTHING SHALL IMPAIR THE INDEPENDENT MEDICAL JUDGMENT OF THE EXECUTIVE. 
  
 2.3 Qualifications and Licensure. The Executive shall at all times during the term of this Agreement: (i) maintain an unlimited and
unrestricted license to practice medicine; (ii) maintain appropriate medical staff membership and privileges at all medical facilities served or serviced by the Executive, and use his best efforts to gain and maintain appropriate medical staff
membership and privileges at any additional medical facilities reasonably identified by the Company; (iii) comply with the applicable Board of Medicine and the Company’s continuing medical education (“CME”) requirements; (iv) carry
out the Executive’s responsibilities on a professional, ethical and diligent basis in order to serve the best interests of the Company’s patients, customers and clients; and (v) comply with such other requirements applicable to all of the
Company’s physician employees as the Board of Directors of the Company may hereinafter impose, including without limitation the Company’s rules, regulations, policies and procedures. 
  
 3. Term of Employment. The term of employment under this Agreement,
and the employment of the Executive hereunder (the “Term of Employment”), shall commence upon execution of this Agreement by both the Executive and the Company and shall terminate upon the date on which the employment of the
Executive is terminated pursuant to and in accordance with Section 6 hereof (the “Expiration Date”). 
  
 4. Compensation. 
  
 4.1 Base Salary. The Executive shall receive a base salary at the annual rate of $450,000 (the “Base Salary”)
during the Term of Employment, with such Base Salary payable in installments consistent with the Company’s normal payroll schedule, subject to applicable withholding and other taxes. The Base Salary shall be reviewed, at least annually, for
merit increases and may, by action and in the discretion of the Board, be increased at any time or from time to time. 
  

 - 2 - 

 4.2 Bonuses. 
  
 a. During the Term of Employment, for each calendar year during the Term of Employment (the “Bonus
Period”), the Board shall establish a bonus pool from which the Executive shall be eligible to receive an annual bonus potentially equal to twenty-five percent (25%) of the Executive’s Base Salary (the “Bonus Payment”), to
be determined by the Board and based upon the satisfaction by the Executive and/or the Company of the goals (the “Goals”), to be established by the Company, on or before April 1 of each calendar year during the Term of Employment.
Notwithstanding the foregoing, in the event that the Goals are either exceeded or not fully achieved for a Bonus Period, the Executive may be eligible to receive a Bonus Payment in an amount in excess of or less than twenty-five percent (25%) of the
Executive’s Base Salary, as determined by the Board in its sole discretion. 
  
 b. For the Bonus Period in which the Executive’s employment with the Company terminates for any reason other than by the Company for
Cause under Section 6.1 hereof, provided that the Executive has been continuously employed with the Company for a minimum of six (6) months during such Bonus Period, the Company shall pay the Executive a pro rata portion (based upon the period
beginning on the first day of the Bonus Period and ending on the date on which the Executive’s employment with the Company terminates) of the bonus otherwise payable under Section 4.2 for the Bonus Period in which such termination of employment
occurs; provided, however, that (i) the Bonus Period shall be deemed to end on the last day of the calendar quarter in which the Executive’s employment so terminates, and (ii) the business criteria used to determine the bonus for this short
Bonus Period shall be annualized and shall be determined based upon audited financial information prepared in accordance with generally accepted accounting principles, applied consistently with prior periods, and reviewed and approved by the
Compensation Committee of the Board. The Incentive Compensation for this Bonus Period is sometimes hereinafter referred to as the “Termination Year Bonus”. 
  
 5. Expense Reimbursement and Other Benefits. 
  
 5.1 Reimbursement of Expenses. Upon the submission of proper substantiation by the Executive, and
subject to such rules and guidelines as the Company may from time to time adopt with respect to the reimbursement of expenses of executive personnel, the Company shall reimburse the Executive for all reasonable expenses actually paid or incurred by
the Executive during the Term of Employment in the course of and pursuant to the business of the Company. The Executive shall account to the Company in writing for all expenses for which reimbursement is sought and shall supply to the Company copies
of all relevant invoices, receipts or other evidence reasonably requested by the Company. 
  
 5.2 Compensation/Benefit Programs. During the Term of Employment, the Executive shall be entitled to participate in all medical,
dental, hospitalization, accidental death and dismemberment, disability, travel and life insurance plans, and any and all other plans as are presently and hereinafter offered by the Company to its executive personnel, including savings, pension,
profit-sharing and deferred compensation plans, subject to the general eligibility and participation provisions set forth in such plans. 
  

 - 3 - 

 5.3 Working Facilities. During the Term of Employment, the Company shall furnish
the Executive with an office, secretarial help and such other facilities and services suitable to his position and adequate for the performance of his duties hereunder. 
  
 5.4 Other Benefits. The Executive shall accrue up to four (4) weeks of paid vacation each calendar
year during the Term of Employment, to be taken at such times as the Executive and the Company shall mutually determine and provided that no vacation time shall significantly interfere with the duties required to be rendered by the Executive
hereunder. Any accrued vacation time not taken by Executive during any calendar year may be carried forward into any succeeding calendar year. Notwithstanding the foregoing, in no event shall the Executive’s accrued vacation time exceed four
(4) weeks at any point in time. The Executive shall receive such additional benefits, if any, as the Board of the Company shall from time to time determine. 
  
 6. Termination. 
  
 6.1 Termination for Cause. The Company shall at all times have the right, upon written notice to the Executive, to terminate the
Term of Employment, for Cause as defined below. For purposes of this Agreement, the term “Cause” shall mean (i) an action or omission of the Executive which constitutes a willful and material breach of, or willful and material
failure or refusal (other than by reason of his disability or incapacity) to perform his duties under, this Agreement which is not cured within fifteen (15) days after receipt by the Executive of written notice of same, (ii) fraud, embezzlement,
misappropriation of funds, breach of trust or material violation of the AmeriPath code of ethics in connection with the Executive’s services under the Employment Agreement or with respect to the Company, (iii) a conviction or indictment of the
Executive for, or entering into a plea of nolo contendere by the Executive with respect to, a felony or any crime which involves dishonesty, fraud, embezzlement, misappropriation of funds or breach of trust, or (iv) gross negligence, reckless or
willful misconduct by the Executive in connection with the performance of the Executive’s duties hereunder, which the Board in its reasonable discretion deems to be good and sufficient cause to terminate the Executive’s employment with the
Company. Any termination for Cause shall be made by notice in writing to the Executive, which notice shall set forth in reasonable detail all acts or omissions upon which the Company is relying for such termination. Upon any termination pursuant to
this Section 6.1, the Company shall pay to the Executive any accrued and unpaid Base Salary and Bonus Payment, through the date of termination. Upon any termination effected and compensated pursuant to this Section 6.1, the Company shall have no
further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination, subject, however, to the provisions of Section 5.1, and payment of compensation for accrued and unused vacation
days). 
  
 6.2 Disability. The Company
shall at all times have the right, upon written notice to the Executive, to terminate the Term of Employment, if the Executive shall become 

  

 - 4 - 

 
entitled to benefits under the Company’s long term disability plan as then in effect, or, if the Executive shall as the result of mental or physical
incapacity, illness or disability, become unable to perform his obligations hereunder for a period of 180 days in any 12-month period. The Board shall have sole discretion based upon competent medical advice to determine whether the Executive is or
continues to be disabled. Upon any termination pursuant to this Section 6.2, the Company shall (i) pay to the Executive any accrued and unpaid Base Salary and Bonus Payment, through the effective date of termination specified in such notice, (ii)
pay to the Executive his Termination Year Bonus, if any, at the time provided in Section 4.2b hereof. Upon any termination effected and compensated pursuant to this Section 6.2, the Company shall have no further liability hereunder (other than for
reimbursement for reasonable business expenses incurred prior to the date of termination, subject, however, to the provisions of Section 5.1, and payment of compensation for accrued and unused vacation days). 
  
 6.3 Death. Upon the death of the Executive during the
Term of Employment, the Company shall (i) pay to the estate of the deceased Executive any accrued and unpaid Base Salary and Bonus Payment, through the Executive’s date of death, (ii) pay to the estate of the deceased Executive, the
Executive’s Termination Year Bonus, if any, at the time provided in Section 4.2b hereof. Upon any termination effected and compensated pursuant to this Section 6.3, the Company shall have no further liability hereunder (other than for
reimbursement for reasonable business expenses incurred prior to the date of termination, subject, however, to the provisions of Section 5.1, and payment of compensation for accrued and unused vacation days). 
  
 6.4 Termination Without Cause. At any time the
Company shall have the right to terminate the Term of Employment by written notice to the Executive. Upon any termination pursuant to this Section 6.4 (that is not a termination under any of Sections 6.1, 6.2, 6.3, 6.5 or 6.6) the Company shall (i)
pay to the Executive any accrued and unpaid Base Salary and Bonus Payment, through the date of termination specified in such notice, (ii) continue to pay the Executive’s Base Salary for a period of twelve (12) months following the termination
of the Executive’s employment with the Company, in the manner and at such times as the Base Salary otherwise would have been payable to the Executive, and (iii) pay to the Executive his Termination Year Bonus, if any, at the time provided in
Section 4.2b. Upon any termination effected and compensated pursuant to this Section 6.4, the Company shall have no further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination,
subject, however, to the provisions of Section 5.1, and payment of compensation for accrued and unused vacation days). 
  
 6.5 Termination by Executive. 
  
 a. The Executive shall at all times have the right, by written notice not less than one hundred and eighty (180) days prior to the
termination date, to terminate his Employment Term. 
  
 b. Upon termination of the Term of Employment pursuant to this Section 6.5 by the Executive, the Company shall pay to the Executive any accrued and unpaid 

  

 - 5 - 

 
Base Salary and Bonus Payment, through the effective date of termination specified in such notice. Upon any termination effected and compensated pursuant to
this Section 6.5, the Company shall have no further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination, subject, however, to the provisions of Section 5.1, and payment of
compensation for accrued and unused vacation days). 
  
 c. If, prior to December 31, 2005, the Executive terminates the Term of Employment pursuant to this Section 6.5, the Executive shall repay to the Company that portion of the $300,000 Signing and Retention Bonus paid to him on November 3,
2000 (“Signing & Retention Bonus”) which is equal to the Signing & Retention Bonus multiplied by a fraction, the numerator of which is the number of full calendar months remaining until December 31, 2005 and the denominator of
which is sixty (60). 
  
 6.6 Change in Control
of the Company. 
  
 a. Unless otherwise
provided in Section 6.7 hereof, in the event that a Change in Control (as defined in paragraph (b) of this Section 6.6) in the Company shall occur during the Term of Employment, the Company shall pay to the Executive, within thirty (30) days of the
date of the Change in Control, a lump sum payment equal to one times the Executive’s annual Base Salary. In addition, if a Change in Control of the Company occurs prior to March 27, 2004, the one-year anniversary of the transaction with Welsh,
Carson, Anderson and Stowe, and the Term of Employment is terminated by the Company without Cause, pursuant to Section 6.4 hereof, the Company shall (1) pay to the Executive any accrued and unpaid Base Salary and Bonus Payment, through the effective
date of the termination, and (2) pay to the Executive, within 30 days of the termination of his employment hereunder, a lump sum payment equal to one times the Executive’s annual Base Salary. The Company shall have no further liability
hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination, subject, however, to the provisions of Section 5.1, and payment of compensation for accrued and unused vacation days). 
  
 b. For purposes of this Agreement, the term “Change
in Control” shall have the meaning ascribed to such term in the Executive’s Time-Based Stock Option Agreement with AmeriPath Holdings, Inc. 
  
 6.7 Certain Reduction of Payments by the Company. 
  
 a. For purposes of this section, (i) A Payment shall mean any payment or distribution in the nature
of compensation to or for the benefit of the Executive, whether paid or payable pursuant to this Agreement or otherwise; (ii) Agreement Payment shall mean a Payment paid or payable pursuant to this Agreement (disregarding this Section 6.7);
(iii) Net After Tax Receipt shall mean the Present Value of a Payment net of all taxes imposed on the Executive with respect thereto under Sections 1 and 4999 of the Code, determined by applying the highest marginal rate under Section 1 of
the Code which applied to the Executive’s taxable income for the immediately preceding taxable year; (iv) “Present Value” shall mean such value 

  

 - 6 - 

 
determined in accordance with Section 280G(d)(4) of the Code; and (v) “Reduced Amount” shall mean the smallest aggregate amount of Payments
which (a) is less than the sum of all Payments and (b) results in aggregate Net After Tax Receipts which are equal to or greater than the Net After Tax Receipts which would result if the aggregate Payments were any other amount equal to or less than
the sum of all Payments. 
  
 b. Anything in this
Agreement to the contrary notwithstanding, in the event that the Company’s independent auditors or, at the Executive’s option, any other nationally or regionally recognized firm of independent accountants selected by the Executive and
approved by the Company, which approval shall not be unreasonably withheld (the “Accounting Firm”), shall determine that receipt of all Payments would subject the Executive to tax under Section 4999 of the Code, it shall determine
whether some amount of Payments would meet the definition of a “Reduced Amount.” If the Accounting Firm determines that there is a Reduced Amount, the aggregate Agreement Payments shall be reduced to such Reduced Amount; provided,
however, that if the Reduced Amount exceeds the aggregate Agreement Payments, the aggregate Payments shall, after the reduction of all Agreement Payments, be reduced (but not below zero) in the amount of such excess. 
  
 c. If the Accounting Firm determines that aggregate
Agreement Payments or Payments, as the case may be, should be reduced to the Reduced Amount, the Company shall promptly give the Executive notice to that effect and a copy of the detailed calculation thereof, and the Executive may then elect, in his
sole discretion, which and how much of the Agreement Payments or Payments, as the case may be, shall be eliminated or reduced (as long as after such election the present value of the aggregate Payments equals the Reduced Amount), and shall advise
the Company in writing of his election within ten days of his receipt of notice. If no such election is made by the Executive within such ten-day period, the Company may elect which of the Agreement Payments or Payments, as the case may be, shall be
eliminated or reduced (as long as after such election the present value of the aggregate Payments equals the Reduced Amount) and shall notify the Executive promptly of such election. All determinations made by the Accounting Firm under this Section
shall be binding upon the Company and the Executive and shall be made within 60 days of a termination of employment of the Executive. As promptly as practicable following such determination, the Company shall pay to or distribute for the benefit of
the Executive such Payments as are then due to the Executive under this Agreement and shall promptly pay to or distribute for the benefit of the Executive in the future such Payments as become due to the Executive under this Agreement. 

 
 d. While it is the intention of the Company and the
Executive to reduce the amounts payable or distributable to the Executive hereunder only if the aggregate Net After Tax Receipts to the Executive would thereby be increased, as a result of the uncertainty in the application of Section 4999 of the
Code at the time of the initial determination by the Accounting Firm hereunder, it is possible that amounts will not have been paid or distributed by the Company to or for the benefit of the Executive pursuant to this Agreement which should not have
been so paid or distributed (“Overpayment”) or that additional amounts which will have not 

  

 - 7 - 

 
been paid or distributed by the Company to or for the benefit of the Executive pursuant to this Agreement could have been so paid or distributed
(“Underpayment”), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm, based either upon the assertion of a deficiency by the Internal Revenue Service against the
Company or the Executive which the Accounting Firm believes has a high probability of success or controlling precedent or other substantial authority, determines that an Overpayment has been made, any such Overpayment paid or distributed by the
Company to or for the benefit of the Executive shall be treated for all purposes as a loan ab initio to the Executive which the Executive shall repay to the Company together with interest at the applicable federal rate provided for in
Section 7872(f)(2) of the Code; provided, however, that no loan shall be deemed to have been made and no amount shall be payable by the Executive to the Company if and to the extent such deemed loan and payment would not either reduce the amount on
which the Executive is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes. In the event that the Accounting Firm, based upon controlling precedent or other substantial authority, determines that an
Underpayment has occurred, any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code. 
  
 6.8 Resignation. Upon any termination of employment
pursuant to this Article 6, the Executive shall be deemed to have resigned as an officer, and if he or she was then serving as a director of the Company, as a director, and if required by the Board, the Executive hereby agrees to immediately execute
a resignation letter to the Board. In addition, the Executive will immediately resign from all staff and similar privileges at any medical facility for which the Company has rendered medical services at any time during the two-year period prior to
the expiration or termination of this Agreement. 
  
 6.9 Survival. The provisions of this Article 6 shall survive the termination of this Agreement, as applicable. 
  
 7. Restrictive Covenants. 
  
 7.1 Non-competition. At all times while the Executive is employed by the Company and for a one (1) year period immediately
following the termination of the Executive’s employment with the Company for any reason, the Executive shall not, directly or indirectly, engage in or have any interest in any sole proprietorship, corporation, company, partnership, association,
venture or business or any other person or entity (whether as an employee, officer, director, partner, agent, security holder, creditor, consultant or otherwise) that directly or indirectly (or through any affiliated entity) competes with the
Company’s business (for purposes of this Agreement, any business that engages in the management or provision of anatomic pathology diagnostic services {whether through physician practices, laboratories, hospitals, medical or surgery centers or
otherwise} shall be deemed to compete with the Company’s business); provided that such provision shall not apply to the Executive’s ownership of common stock of the Company or the acquisition by the Executive, solely as an investment, of
securities of any issuer that are registered under Section 12(b) or 12(g) of the Securities Exchange Act of 

  

 - 8 - 

 
1934, as amended, and that are listed or admitted for trading on any United States national securities exchange or that are quoted on the National
Association of Securities Dealers Automated Quotations System, or any similar system or automated dissemination of quotations of securities prices in common use, so long as the Executive does not control, acquire a controlling interest in or become
a member of a group which exercises direct or indirect control of, more than five percent (5.0%) of any class of capital stock of such corporation. 
  
 7.2 Confidential Information. The Executive shall not at any time divulge, communicate, use to the detriment of the Company or for
the benefit of any other person or persons, or misuse in any way, any Confidential Information (as hereinafter defined) pertaining to the business of the Company. Any Confidential Information or data now or hereafter acquired by the Executive with
respect to the business of the Company (which shall include, but not be limited to, information concerning the Company’s financial condition, prospects, technology, customers, suppliers, employees, employee compensation or benefits, employment
practices and methods of doing business) shall be deemed a valuable, special and unique asset of the Company that is received by the Executive in confidence and as a fiduciary, and Executive shall remain a fiduciary to the Company with respect to
all of such information. For purposes of this Agreement, “Confidential Information” means information disclosed to the Executive or known by the Executive as a consequence of or through the unique position of his employment with the
Company (including information conceived, originated, discovered or developed by the Executive) prior to or after the date hereof, and not generally or publicly known, about the Company or its business. Notwithstanding the foregoing, nothing herein
shall be deemed to restrict the Executive from disclosing Confidential Information to promote the best interests of the Company or to the extent required by law. 
  
 7.3 Nonsolicitation of Employees and Customers. At all times while the Executive is employed by the
Company and for the two (2) year period immediately following the termination of the Executive’s employment with the Company for any reason, the Executive shall not, directly or indirectly, for himself or for or on behalf of any other person,
firm, corporation, partnership, association or other entity (a) employ or attempt to employ or solicit the termination of employment of or enter into any contractual arrangement with any employee or former employee of the Company, unless such
employee or former employee has not been employed by the Company for a period in excess of six (6) months, and/or (b) call on or solicit any of the actual or targeted prospective customers or clients of the Company (or of its physician practices or
laboratories) on behalf of any person or entity in connection with any business that competes with the Company’s business, nor shall the Executive make known the names and/or addresses of such employees, customers or clients or any information
relating in any manner to the Company’s trade or business relationships with such employees, customers or clients, other than in connection with the performance of Executive’s duties under this Agreement. 
  
 7.4 Ownership of Developments. All copyrights,
patents, trade secrets, or other intellectual property rights associated with any ideas, concepts, techniques, inventions, processes, or works of authorship developed or created by Executive during the course of performing work for the Company or
its clients (collectively, the “Work Product”) shall belong 

  

 - 9 - 

 
exclusively to the Company and shall, to the extent possible, be considered a work made by the Executive for hire for the Company within the meaning of Title
17 of the United States Code. To the extent the Work Product may not be considered work made by the Executive for hire for the Company, the Executive agrees to assign, and automatically assign at the time of creation of the Work Product, without any
requirement of further consideration, any right, title, or interest the Executive may have in such Work Product. Upon the request of the Company, the Executive shall take such further actions, including execution and delivery of instruments of
conveyance, as may be appropriate to give full and proper effect to such assignment. 
  
 7.5 Books and Records. All books, records, and accounts relating in any manner to the customers or clients of the Company, whether
prepared by the Executive or otherwise coming into the Executive’s possession, shall be the exclusive property of the Company and shall be returned immediately to the Company on termination of the Executive’s employment hereunder or on the
Company’s request at any time. 
  
 7.6
Definition of Company. Solely for purposes of this Article 7, the term “Company” also shall include any existing or future subsidiaries of the Company that are operating during the time periods described herein and any other
entities that directly or indirectly, through one or more intermediaries, control, are controlled by or are under common control with the Company during the periods described herein. 
  
 7.7 Acknowledgment by Executive. The Executive acknowledges and confirms that (a) the restrictive
covenants contained in this Article 7 are reasonably necessary to protect the legitimate business interests of the Company, and (b) the restrictions contained in this Article 7 (including without limitation the length of the term of the provisions
of this Article 7) are not overbroad, overlong, or unfair and are not the result of overreaching, duress or coercion of any kind. The Executive acknowledges and confirms that his special knowledge of the business of the Company is such as would
cause the Company serious injury or loss if he were to use such ability and knowledge to the benefit of a competitor or were to compete with the Company in violation of the terms of this Article 7. The Executive further acknowledges that the
restrictions contained in this Article 7 are intended to be, and shall be, for the benefit of and shall be enforceable by, the Company’s successors and assigns. 
  
 7.8 Reformation by Court. In the event that a court of competent jurisdiction shall determine that
any provision of this Article 7 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then only as to enforcement of this Article 7 within the jurisdiction of such court, such provision shall be interpreted and
enforced as if it provided for the maximum restriction permitted under such governing law. 
  
 7.9 Extension of Time. If the Executive shall be in violation of any provision of this Article 7, then each time limitation set
forth in this Article 7 shall be extended for a period of time equal to the period of time during which such violation or violations occur. If the Company seeks injunctive relief from such violation in any court, then the covenants set forth in this
Article 7 shall be extended for a period of time equal to the pendency of such proceeding including all appeals by the Executive. 
  

 - 10 - 

 7.10 Survival. The provisions of this Article 7 shall survive the termination of
this Agreement, as applicable. 
  
 8. Injunction. It is
recognized and hereby acknowledged by the parties hereto that a breach by the Executive of any of the covenants contained in Article 7 of this Agreement will cause irreparable harm and damage to the Company, the monetary amount of which may be
virtually impossible to ascertain. As a result, the Executive recognizes and hereby acknowledges that the Company shall be entitled to an injunction from any court of competent jurisdiction enjoining and restraining any violation of any or all of
the covenants contained in Article 7 of this Agreement by the Executive or any of his affiliates, associates, partners or agents, either directly or indirectly, and that such right to injunction shall be cumulative and in addition to whatever other
remedies the Company may possess. 
  
 9. Arbitration. Any
dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration in Palm Beach County, Florida, in accordance with the Rules of the American Arbitration Association then in effect (except to the
extent that the procedures outlined below differ from such rules). Within thirty (30) days after written notice by either party has been given that a dispute exists and that arbitration is required, each party must select an arbitrator and those two
arbitrators shall promptly, but in no event later than thirty (30) days after their selection, select a third arbitrator. The parties agree to act as expeditiously as possible to select arbitrators and conclude the dispute. The selected arbitrators
must render their decision in writing. The cost and expenses of the arbitration and of enforcement of any award in any court shall be borne by the non-prevailing party. If advances are required, each party will advance one-half of the estimated fees
and expenses of the arbitrators. Judgment may be entered on the arbitrators’ award in any court having jurisdiction. Although arbitration is contemplated to resolve disputes hereunder, either party may proceed to court to obtain an injunction
to protect its rights hereunder, the parties agreeing that either could suffer irreparable harm by reason of any breach of this Agreement. Pursuit of an injunction shall not impair arbitration on all remaining issues. 
  
 10. Section 162(m) Limits. Notwithstanding any other provision of this
Agreement to the contrary, if and to the extent that any remuneration payable by the Company to the Executive for any year would exceed the maximum amount of remuneration that the Company may deduct for that year under Section 162(m)
(“Section 162(m)”) of the Code, payment of the portion of the remuneration for that year that would not be so deductible under Section 162(m) shall, in the sole discretion of the Board, be deferred and become payable at such time or
times as the Board determines that it first would be deductible by the Company under Section 162(m), with interest at the “short-term applicable rate” as such term is defined in Section 1274(d) of the Code. The limitation set forth under
this Section 10 shall not apply with respect to any amounts payable to the Executive pursuant to Article 6 hereof. 
  
 11. Assignment. Neither party shall have the right to assign or delegate his rights or obligations hereunder, or any portion thereof, to any other
person. 
  

 - 11 - 

 12. Governing Law. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of Florida, without reference to principles of conflict of laws. 
  
 13. Entire Agreement; Prior Agreements. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and, upon its effectiveness, shall supersede all
prior agreements, understandings and arrangements, both oral and written, between the Executive and the Company (or any of its affiliates) with respect to such subject matter. In addition, this shall supercede and replace the Executive’s Prior
Employment Agreement, as well as any and all other agreements between the Executive and the Company and, upon execution of this Agreement by the Executive and the Company, the Prior Employment Agreement and any and all other agreements between the
Executive and the Company shall terminate and shall no longer have any force and effect. Notwithstanding this Article 13 or any other provision of this Agreement, Option Agreements entered into by the Executive and the Company prior to the date of
this Agreement shall remain in full force and effect. This Agreement may not be modified in any way unless by a written instrument signed by both the Company and the Executive. 
  
 14. Notices: All notices and other communications hereunder shall be in writing and shall be given by hand delivery
to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
  
 If to the Executive: 
  
 JEFFREY A. MOSSLER, M.D. 
 1005 Laurelwood
Road 
 Carmel, IN 46032 
  
 If to the Company: 
  
 AmeriPath, Inc. 
 7289 Garden Road, Suite 200

 Riviera Beach, FL 33404 
 Attention: Chairman of the Board 
  
 or to such other address as either
party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee. 
  

15. Benefits; Binding Effect. This Agreement shall be for the benefit of and binding upon the parties hereto and their respective heirs,
personal representatives, legal representatives, successors and, where permitted and applicable, assigns, including, without limitation, any successor to the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise.

  

 - 12 - 

 16. Severability. The invalidity of any one or more of the words, phrases, sentences, clauses,
provisions, sections or articles contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event
that any one or more of the words, phrases, sentences, clauses, provisions, sections or articles contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase or phrases, sentence
or sentences, clause or clauses, provision or provisions, section or sections or article or articles had not been inserted. If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered
to be reduced to a period or area which would cure such invalidity. 
  
 17. Waivers. The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation. 
  
 18. Damages. Nothing contained herein shall be construed to prevent
the Company or the Executive from seeking and recovering from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement. In the event that either party hereto brings suit for
the collection of any damages resulting from, or the injunction of any action constituting, a breach of any of the terms or provisions of this Agreement, then the party found to be at fault shall pay all reasonable court costs and attorneys’
fees of the other. 
  
 19. Section Headings. The article,
section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
  
 20. No Third Party Beneficiary. Nothing expressed or implied in this Agreement is intended, or shall be construed, to
confer upon or give any person other than the Company, the parties hereto and their respective heirs, personal representatives, legal representatives, successors and permitted assigns, any rights or remedies under or by reason of this Agreement.

  
 21. Withholding Taxes. The Company may withhold from
any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation. 
  
 22. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which
together shall constitute one and the same instrument and agreement. 
  

 - 13 - 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

  

			
	COMPANY:
	
	 AMERIPATH, INC.

		
	By:	 	 /s/ James C. New

	 	 	 James C. New

	 	 	 Chairman & Chief Executive Officer

  

			
	EXECUTIVE:
	
	 /s/ Jeffrey A. Mossler

	 JEFFREY A. MOSSLER, M.D.

  

 - 14 -Employment Agreement for Stephen W. Aldred, M.D.

 EXHIBIT 10.8 
  
 AMERIPATH DALLAS 
  
 EMPLOYMENT AGREEMENT 
  
 EMPLOYMENT AGREEMENT (the “Agreement”) entered into as of September 2, 1997, by and between DFW 5.01(a) Corporation, a Texas not for
profit corporation certified to practice medicine by the Texas Board of Medicine pursuant to Section 5.01 (a) of the Texas Medical Practices Act doing business as AMERIPATH DALLAS (the “Company”), and STEPHEN W. ALDRED, M.D.
(the “Employee”). 
  
 WHEREAS, prior to the
date hereof, the Employee served as an employee of and rendered professional services, as a Doctor of Medicine specializing in Pathology, to one of a group of related Texas entities (the “Unipath Entities”) providing pathology services.
Pursuant to a certain Stock Purchase Agreement (the “Purchase Agreement”) dated as of August 21, 1997, which is an otherwise validly enforceable agreement by and among AmeriPath, Inc., a Delaware corporation (“AmeriPath”), and
the ultimate beneficial owners and shareholders of the Unipath Entities, all of the capital stock of and interests of, in or to the Unipath Entities has been purchased by and sold, transferred and conveyed to AmeriPath and the Company (the
“Acquisition”), effective the date hereof. 
  
 WHEREAS, accordingly, and in connection with the transactions and agreements referred to above, the Employee has agreed to terminate his employment with the Unipath Entities and to become employed by and render professional services,
as a Doctor of Medicine specializing in Pathology, to the Company, and the Company has agreed to engage the Employee to render such services on the Company’s behalf, in each case on the terms and subject to the conditions set forth herein.

  
 NOW, THEREFORE, for and in consideration of the
foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Employee and the Company, intending to be legally bound,
hereby agree as follows: 
  
 1. Employment. Subject
to the terms and conditions of this Agreement, the Company shall employ the Employee to render professional services as a Doctor of Medicine specializing in Pathology, and the Employee accepts such employment. The Employee has terminated his
employment with the Unipath Entities. 
  
 2. Term.
The Company shall employ the Employee for a period commencing the date hereof and ending on September 2, 2002, subject to termination prior to such date pursuant to Section 15 or 17 hereof. At the end of such five (5) year period, this Agreement
will automatically continue in effect for additional one (1) year terms unless either party gives written notice to the other at least sixty (60) days prior to the end of such term (or any extension thereof) 

  

 
of such party’s determination to terminate the Employee’s employment hereunder, notwithstanding anything to the contrary contained herein. If such
notice is given, then the Employee’s employment will terminate at the end of such term (or on such other date as the parties mutually agree). If such notice is not given, then the Employee’s employment will continue hereunder for an
additional year, subject to termination prior to such date pursuant to Section 15 or 17 hereof. 
  
 3. Duties and Performance. The Employee agrees to devote the Employee’s best efforts and full professional time to providing services
in the practice of medicine on the Company’s behalf, and the Employee shall maintain the Company’s standards and professional ethics and those of the medical profession. In addition to rendering professional services as the Company’s
employee, the Employee is also expected as part of the Employee’s duties as the Company’s employee to engage in marketing activities designed to promote the Company’s practice, as well as administrative and compliance activities, all
as directed by the Board of Directors of the Company. Except as may be permitted in writing by the Company, the Employee is not to practice medicine other than with the Company during the term of this Agreement (and thereafter, pursuant to Section
20 hereof), nor is the Employee to engage in any other gainful occupation without the Company’s prior written consent. The preceding sentence is not intended to prohibit the Employee from engaging in the practice of medicine in the course of
the Employee’s duties as a member of the U.S. Military, either active or reserve, or the National Guard. The Employee may also (i) engage in personal investment activities as long as those investments do not impair the Employee’s ability
to provide services hereunder; (ii) participate in community activities or (iii) render consultation services in connection with litigation matters or give testimony in any action or proceeding as an expert witness; provided such services or
testimony does not have an adverse effect on the Company or AmeriPath; provided such activities set forth in the preceding clauses (i), (ii) and (iii) above do not impose additional liability on the Company or Ameripath and do not detract from the
Employee’s ability to perform the Employee’s duties to the Company. Additional duties of the Employee are set forth below in this Agreement. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN, NOTHING SHALL IMPAIR THE
INDEPENDENT MEDICAL JUDGMENT OF THE EMPLOYEE. 
  
 4.
Qualifications and Licensure. The Employee shall at all times during the term of this Agreement: (i) be certified by the American Board of Pathology in at least anatomic pathology or be Board Eligible; (ii) maintain an unlimited and
unrestricted license to practice medicine in the State of Texas; (iii) maintain appropriate medical staff membership and privileges at all medical facilities presently served or serviced by the Employee, and use his best efforts to gain and maintain
appropriate medical staff membership and privileges at any additional medical facilities jointly identified by the Company and the Employee; (iv) comply with the Texas Board of Medicine and the Company’s continuing medical education
(“CME”) requirements, as required by the Managing Director; (v) carry out the Employee’s responsibilities on a professional, ethical and diligent basis in order to serve the best interests of the Company’s patients, customers and
clients; and (vi) comply with such other requirements applicable to all of the Company’s physician employees as the Board of Directors of the Company may hereinafter reasonably 

  

 
impose, including without limitation the Company’s rules, regulations, policies and procedures (the “Rules and Regulations”). 
  
 5. Medical Facilities; Location. At present, the Company
furnishes pathology and laboratory services to the medical facilities set forth on Annex A to this Agreement (subject to change from time to time as the Company enters into contracts with additional hospitals and/or facilities or as existing
contracts with medical facilities terminate or expire). The Employee will accept assignment for duty in any reasonable location in the Dallas, Texas Metropolitan area at which the Company renders pathology services during the term of this Agreement
and to perform such duties as the Company may direct. 
  
 6.
Conformity with Laws, Rules, Regulations and Policies. In performing the Employee’s duties under this Agreement, the Employee shall comply with (i) all applicable laws, rules and regulations, ordinances and standards of any
governmental, quasi-governmental or private authority having either mandatory or voluntary jurisdiction over the Company, the Employee, or any medical facility for which the Employee provides services, (ii) the written bylaws, rules and regulations,
policies and procedures of any such medical facility, including, without limitation, the residential boundary requirements of such hospitals or medical facilities, and (iii) the Company’s Rules and Regulations. 
  
 7. Salary; Fringe Benefits. During the term of the
Employee’s employment under this Agreement, in consideration for all services rendered for and on behalf of the Company, the Employee shall be entitled to receive a salary at the annual rate of $225,000, payable in accordance with the
Company’s regular payroll practices in effect from time to time. In addition to the Employee’s salary, the Employee will also be entitled to fringe benefits (including medical and retirement benefits) comparable to those which the Company
provides to other physician employees having tenure, experience, specialties, responsibilities, educational background and other qualifications similar to those of the Employee. The Employee’s hours shall be reasonable and comparable to other
like physicians in similar positions within the Company. 
  
 8.
Reimbursement of Expenses. 
  
 (a) Upon submission of proper documentation and approval by the Managing Director (the physician chosen by the Board of Directors of the Company from time to time to manage the medical aspects of the Company), the Company will reimburse the
Employee’s reasonable moving and transportation expenses incurred in connection with the Employee’s relocation and employment with the Company. 
  
 (b) Further, upon submission of proper documentation and approval by the Managing Director, the Company will reimburse the Employee’s
reasonable expenses incurred in connection with the Employee’s employment by the Company, subject to compliance with reimbursement policies from time to time adopted by the Company. Reimbursable expenses, subject to the Managing Director’s
prior approval, include: 
  
 (1) License fees and
membership dues in professional organizations. 
  

 - 3 - 

 (2) The Employee’s necessary travel, room, board and other expenses incurred in
providing services at the Company’s request or otherwise for the benefit of the Company. 
  
 (3) The Employee’s business expenses if ordinary and necessary and in furtherance of the Company’s business. 
  
 (c) Expenses with respect to CME and subscriptions to
professional and business journals and books shall be borne and paid solely by the Employee as incurred. 
  
 9. Malpractice Insurance. 
  
 (a) While the Employee is Employed by the Company. The Company shall maintain policies of professional liability insurance on the
Employee (including coverage for prior acts) and the Company’s other employees in such amounts and on such terms as the Company may determine; provided that such amounts of coverage shall be equal to or greater than $1,000,000 per
occurrence/$5,000,000 in the aggregate, including surplus levels of coverage of $5,000,0000 and $10,000,000 with limits in the aggregate of $16,000,000 and $20,000,000 per physician. The Employee shall comply with any requirements or standards
imposed on the Employee or the Company by the terms of the insurance, and the Employee shall furnish such information as the insurer or the Company shall require. The Company shall advise the Employee of any changes with respect to the insurer or
the insurance coverages as set forth herein. The Employee may recommend counsel to handle medical malpractice claims, subject to the prior written approval of the insurer. 
  
 (b) Tail Coverage. 
  
 (1) If the Employee’s employment is terminated for cause (as defined in Section 15 hereof) or if the
Employee terminates his employment with the Company for any reason, other than for “good reason” (as defined in Section 15(b) hereof) or the death or Disability (as defined in Section 17(b)) of the Employee, then, except as hereinafter
provided, the Company shall have the option, but not the obligation, of purchasing malpractice insurance “tail” coverage, for the period of the applicable statute of limitations, to provide coverage for the Employee’s professional
acts prior to the date of termination. If the Company acquires this “tail” coverage, its cost shall be borne and paid by the Employee. If the Employee fails to provide and pay for such tail coverage, then the Company shall have the right
to obtain such tail coverage and deduct and set-off its cost from payments otherwise payable to the Employee. 
  
 (2) If the Employee’s employment terminates for any reason other than those set forth in (1) above, the Company, at its sole cost and
expense, shall obtain “tail” coverage. Notwithstanding the foregoing, if, after termination of employment, the 

  

 - 4 - 

 
Employee continues in the practice of medicine and maintains malpractice insurance that includes coverage for the Employee’s acts prior to termination
of employment, then the Employee shall cause the Company to be a named insured as to those prior acts. 
  
 10. Fees; Payments. The Company has, and hereby reserves, the sole and exclusive authority to determine the fees (or a procedure for
establishing the fees), in consultation with the Managing Director, to be charged to the Company’s patients, customers and clients. All fees for professional services rendered by the Employee during the term of this Agreement shall be the
Company’s sole and exclusive property (subject to the contract rights of certain third parties). If, for any reason, any checks or other payments for such services are made payable to the Employee, the Employee will endorse and deliver those
checks or payments to the Company. The Employee also hereby authorizes the Company to endorse and negotiate on the Employee’s behalf any such checks or payments. In addition, the Employee agrees, upon the Company’s request, to account to
the Company for any such fees which may have been received by the Employee. 
  
 11. Acceptance of Patients. The Company shall have the sole and exclusive authority, in consultation with the Managing Director, to determine who will be accepted as patients of the Company’s
practice and to designate, and establish a procedure for designating, which professional employee of the Company will handle each such patient. 
  
 12. Professional Rules and Regulations. The Company shall at all times have the exclusive authority to establish reasonable professional
policies and procedures to be followed by the Employee in rendering professional services on the Company’s behalf, and the Employee agrees to follow the Rules and Regulations established by the Company from time to time. The Rules and
Regulations shall, where applicable and appropriate, be applied on a consistent basis to all of the Company’s physician employees. 
  
 13. Medical Records as Company Property. All medical records, charts, case histories, x-rays, specimens, tissue samples and lab reports and
analyses of or concerning patients of the Company (“Medical Records”) received by the Employee shall be and remain the Company’s property. During the term of this Agreement and thereafter, the Employee will comply with all of the
Company’s Rules and Regulations regarding confidentiality of the Medical Records. The Employee shall have the right to copies of such Medical Records that are necessary for defense of litigation or are required for patients. 
  
 14. Paid Vacation and Time Off. The Employee shall be entitled
to a total of six (6) weeks of paid leave time per year (pro rated for any period of employment of less than an entire year), said leave time to include vacation time, other time off and such time as may be taken by the Employee to satisfy the
Employee’s applicable CME requirements. All leave time must be coordinated with and approved by the Managing Director to ensure adequate coverage of the Company’s patients, customers and clients. All paid leave time must be taken during
the year in which it is earned and available, and thus will not be carried forward or usable in any subsequent year unless the Employee receives the prior written consent of the Managing Director. 

  

 - 5 - 

 
No cash payments will be made by the Company in respect of any earned but unused paid leave time. 
  
 15. Termination of Agreement. 
  
 (a) Termination for Cause. The Company may, in its
sole and absolute discretion, terminate the employment of the Employee hereunder, at any time prior to the expiration of the Employee’s employment term(s) hereunder, immediately upon written notice to the Employee, or at such later time as the
Company may specify in such notice, if such termination is for “cause”. As used in this Agreement, the term “cause” includes only the following: 
  
 (1) If the Employee’s right to practice medicine in any state is suspended, restricted, revoked, lapsed
(other than a lapse due to the Employee’s voluntary failure to maintain such license after becoming a nonresident of that state); 
  
 (2) If the Employee (i) willfully damages the Company’s property, business, reputation or goodwill (ii) steals from the Company,
(iii) commits fraud or (iv) embezzles. 
  
 (3) If
the Employee is convicted of a felony or another crime or violation of moral turpitude or a violation of a health care law; 
  
 (4) If, in the opinion of and subject to the discretion of the Physician Committee (as defined in Section 15(d) below), the Employee is
continually inattentive to, or neglectful of, the duties to be performed by the Employee, which inattention or neglect is not the result of illness or injury; 
  

(5) If, in the opinion of and subject to the discretion of the Physician Committee, the Employee uses any mood altering or controlled
substances except as prescribed by a physician, or if the Employee uses alcohol to excess; 
  
 (6) If the Employee willfully injures any independent contractor, employee, or agent of the Company, or willfully injures any person in
the course of the performance of services for or on behalf of the Company; 
  
 (7) If, in the opinion of and subject to the discretion of the Physician Committee, the Employee’s medical staff privileges or membership in any medical facility are suspended, restricted, revoked (other than a
revocation occurring solely because the Employee has voluntarily ceased to perform medical services at such hospital with the Company’s consent), placed under probation, proctoring or observation and case review; 
  
 (8) Subject to the Physician Committee’s discretion, if
a guardian or conservator for the Employee is appointed by a court of competent jurisdiction; 
  

 - 6 - 

 (9) If, in the opinion of and subject to the discretion of the Physician Committee, the
Employee sexually harasses any employee or contractor of the Company or commits any act which otherwise creates an offensive work environment for employees or contractors of the Company; or 
  
 (10) The Company is unable to obtain the malpractice
insurance required to be obtained by the Company hereunder, according to terms reasonably satisfactory to the Company and that are consistent with industry practice; 
  
 (11) The Employee’s failure for any reasons to maintain the Employee’s board certification in the
medical specialty of Pathology; 
  
 (12) If the
Employee fails to materially comply with any of the terms or conditions of this Agreement or any term or condition of any agreement between the Company and a medical facility for which the Company provides services, and such failure to comply shall
continue for a period of thirty (30) days after notice thereof by the Company. 
  
 provided, however, with respect to paragraphs (4) and (5) above, the Company or the Physician Committee shall have provided the Employee with written notice specifying the objectionable behavior, and, within thirty
(30) days of receipt of the notice, the Employee shall have failed to cure such behavior or, in the sole judgment of the Company or the Physician Committee, as the case may be (as set forth above), failed to demonstrate reasonable progress towards
curing such behavior. 
  
 The Company shall not
be limited to termination as a remedy for any damaging, injurious, improper or illegal act by the Employee, but may also seek damages, injunction, or such other remedy as the Company may deem appropriate under the circumstances. If the
Employee’s employment is terminated for cause, the Employee agrees to vacate the Company’s offices on or before the effective date of the termination and to return and deliver to the Company at such time all Company property. 

 
 (b) Termination by the Employee. Provided that the
Company does not have “cause” to terminate the Employee pursuant to subsection “a” above, the Employee may terminate the Employee’s employment with the Company hereunder at any time and for any reason; provided,
however, the Employee must provide to the Company written notice of such determination not less than 120 days prior to the date such termination is to be effective, and the Employee shall be entitled to receive and be paid solely the
Employee’s salary then in effect, through the effective date of such termination, payable during such period at the Company’s regular and customary intervals for the payment of salaries as then in effect, and the Company shall have no
further obligation or liability to the Employee hereunder. 
  
 (c) Termination by the Company without Cause. The Company may, in its sole and absolute discretion (in accordance with the procedures set forth in subsection (d) below), 

  

 - 7 - 

 
terminate the employment of the Employee hereunder, at any time prior to the expiration of the Employee’s employment term(s) hereunder, without
“cause” (as such term is defined in subsection (a) above), or otherwise without any cause, reason or justification, provided that the Company provides to the Employee at least ninety (90) days’ prior written notice (the
“Termination Notice”) of such termination. In the event of any such termination by the Company, (i) the Employee’s employment with the Company shall cease and terminate on the date specified in the Termination Notice (or, if no date
is so specified, on the date which is 90 days following the date of such notice), and (ii) the Employee shall be entitled to receive and be paid solely the Employee’s salary then in effect, through the date which is one year following the
termination date specified in the Termination Notice (or, if earlier, one year following the date of such notice), payable during such year at the Company’s regular and customary intervals for the payment of salaries as then in effect, and the
Company shall have no further obligation or liability to the Employee hereunder. 
  
 (d) Procedure for Termination by Company without Cause. 
  
 (i) Except in the case of a termination without cause of the Employee under the circumstances identified in
clause (ii) below of this Subsection (d), any termination of the Employee’s employment hereunder pursuant to Subsection (c) above shall first be considered, recommended and approved by a committee (the “Physician Committee”)
consisting of (a) three physician employees working out of the Company’s Unipath Division, who shall be appointed and designated by a majority of the physician employee’s then working out of the Company’s Unipath Division, one of whom
shall be the Managing Director (but none of whom may be the Employee), and (b) two physicians, who are employees of the Company or of any Affiliate of the Company, which physicians shall be appointed and designated by the Board of Directors of
AmeriPath. 
  
 (ii) If, at any time, either of
the following two events or circumstances shall occur: 
  
 (1) the Operating Earnings (as such term is defined in the Purchase Agreement) for the 12 full calendar month period preceding the date in question (i.e., the date the termination of employment is considered),
are equal to or less than $6,2300,000; or 
  
 (2) the termination, for any cause, reason or justification whatsoever, or lapsing of any contract the Company has with a hospital or medical facility which contract produced annual revenue of $500,000 or more (a) prior to the date hereof,
to any of the Unipath Entities, and (b) after the date hereof, to the Company. 
  
 then, in either such event, the Company may, in its sole and absolute discretion, terminate the employment of the Employee hereunder pursuant to Subsection (c) above, without “cause” (as such term is defined in Subsection (a)
above), or otherwise without any cause, reason or justification, which termination (i) may first be considered by the Physician Committee for a 

  

 - 8 - 

 
period not to exceed thirty (30) days from the first written notice on the issue to the Managing Director from the Board of Directors of AmeriPath, and (ii)
is subject to authorization and approval only by the Board of Directors of AmeriPath, in their sole and absolute discretion. 
  
 16. The Employee’s Duties upon Expiration or Termination. If this Agreement expires or is otherwise terminated for any reason:

  
 (a) Unless the Employee and the Company
otherwise agree in writing, the Employee will immediately resign from all (i) director, officer, fiduciary and/or trustee positions held with the Company, and (ii) staff and similar privileges at any medical facility for which the Company has
rendered medical services at any time during the two-year period prior to the expiration or termination of this Agreement. 
  
 (b) The Employee will immediately return to the Company all books and records of the Company in the Employee’s possession, including,
but not limited to, books and records relating to pathology services rendered by the Employee under this Agreement, Medical Records, meeting minutes, board summaries and financial reports or data. 
  
 (c) The Employee shall not be required to seek other
employment or otherwise mitigate to reduce any amounts the Company may owe the Employee. 
  
 17. Termination of Employment Upon Death or Disability. 
  
 (a) Death of the Employee. In the event that the Employee shall die during the term of his employment under this Agreement, the
Employee’s employment with the Company shall immediately cease and terminate and the Employee’s estate, heirs (at law), devisees, legatees or other proper and legally-entitled descendants, or the personal representative, executor,
administrator or other proper legal representative on behalf of such descendants, shall be entitled to receive and be paid solely the Employee’s salary, then in effect, for a period of 60 days, payable at the Company’s regular and
customary intervals for the payment of salaries as then in effect, and the Company shall have no further obligation or liability under this Agreement (other than for any reimbursement of reasonable out-of-pocket business expenses properly incurred
by the Employee prior to his death and documented to the Company in accordance herewith). 
  
 (b) Disability of the Employee. In the event that the Employee becomes incapacitated during the term of his employment hereunder by
reason of sickness, accident or other mental or physical disability such that he is substantially unable to perform his duties and responsibilities hereunder for a period of 60 consecutive days, or for shorter or intermittent periods aggregating 90
days during any 12-month period (a “Disability”), the Company thereafter shall have the right, in its sole and absolute discretion, to terminate the Employee’s employment under this Agreement by sending written notice of such
termination to the Employee or his legal guardian or other proper legal representative and thereupon his employment hereunder shall immediately cease and terminate. In the event of any such termination, the Employee shall be 

  

 - 9 - 

 
entitled to receive and be paid solely his salary, then in effect, for a period of 60 days, payable at the Company’s regular and customary intervals for
the payment of salaries as then in effect, less any amounts, payments or benefits the Employee might receive under the Company’s disability insurance policy, and the Company shall have no further obligation or liability under this Agreement
(other than for any reimbursement of reasonable out-of-pocket business expenses properly incurred by Employee prior to his Disability and documented to the Company in accordance herewith). 
  
 18. Limitations on Authority. Unless the Company has given the
Employee its express written consent, the Employee has absolutely no authority to: 
  
 (a) Pledge the credit or assets of the Company (or any Affiliate of the Company) or of any of the Company’s other employees.

  
 (b) Bind the Company (or any Affiliate of the
Company) under any contract, agreement, note, mortgage or other instrument (other than routine purchase orders in the ordinary course of business consistent with the Company’s practices). 
  
 (c) Release or discharge any debt due the Company (or any
Affiliate of the Company). 
  
 (d) Sell,
mortgage, transfer or otherwise dispose of any of the Company’s assets (or any assets of any Affiliate of the Company). 
  
 19. Representations of Employee. The Employee represents and warrants at all times during the term of this Agreement that: 
  
 (a) The Employee is duly licensed and registered and in good
standing under the laws of the State of Texas to engage in the practice of medicine, and that said license and registration have not been suspended, revoked or restricted in any manner. 
  
 (b) The Employee is qualified for and has obtained, or has applied for, membership in good standing on the
medical staff of each hospital in which, in the opinion of the Physician Committee, such privileges are necessary for the Employee to render services. 
  
 (c) The Employee has and will continue to truthfully disclose to the Company the following matters, whether occurring, at any time during
the five (5) years immediately preceding the date of this Agreement or at any time during the term of this Agreement: 
  
 (1) any actual or threatened malpractice suit, claim (whether or not filed in court), settlement, settlement allocation, judgment, verdict
or decree against the Employee; 
  

 - 10 - 

 (2) any disciplinary, peer review or professional review investigation, proceeding or
action instituted against the Employee by any licensure board, hospital, medical school, health care facility or entity, professional society or association, third party payor, peer review or professional review committee or body, or governmental
agency; 
  
 (3) any criminal complaint,
indictment or criminal proceeding in which the Employee is named as a defendant; 
  
 (4) any allegation, investigation, or proceeding, whether administrative, civil or criminal, against the Employee of filing false health
care claims, violating anti-kickback laws, violating self-referral laws, violating fee splitting laws, or engaging in other billing improprieties; 
  
 (5) any organic or mental illness or condition that impairs or is likely to impair the Employee’s ability to practice medicine;

  
 (6) any dependency on, or habitual use or
abuse of, alcohol or controlled substances, or any participation in any alcohol or controlled substance detoxification, treatment, recovery, rehabilitation, counseling, screening or monitoring program; 
  
 (7) any allegation, investigation or proceeding, whether
administrative, civil, or criminal, against the Employee for violating professional ethics or standards, or engaging in illegal, immoral or other misconduct (of any nature or degree), relating to the practice of medicine; and 
  
 (8) any denial or withdrawal of an Employee’s
application in any state for licensure as a physician, for medical staff privileges at any hospital or other health care entity, for recertification, for participation in any third-party payment program, for state or federal controlled substances
registration, or for malpractice insurance, or loss of board certification in the medical specialty of anatomic pathology or in the medical specialty of general pathology for any reason whatsoever. 
  
 (d) The Employee is board certified or board eligible in the
medical specialty of pathology. 
  
 (e) The
Employee shall at all times render services to patients in a competent, professional and ethical manner, in accordance with prevailing standards of medical practice in the relevant community, perform professional and supervisory services in
accordance with recognized standards of the medical profession, and act in a manner consistent with the Principles of Medical Ethics of the American Medical Association, American Board of Pathology and all applicable statutes, regulations, rules,
orders and directives of any and all applicable governmental and regulatory bodies having competent jurisdiction. 
  

 - 11 - 

 (f) In connection with the provision of professional services to patients of Company, the
Employee shall use the equipment, instruments, Pharmaceuticals and supplies furnished by or on behalf of the Company for the purposes for which they are intended and in a manner consistent with sound medical practice. 
  
 (g) The Employee shall participate in Medicare, Medicaid,
workers compensation, other federal and state reimbursement programs, and the payment plan of any commercial insurer, health maintenance organization, preferred provider organization, accountable health plan, or other health benefit program, as
directed by the Company, and the Employee has not been suspended or excluded from participating in any such program. 
  
 (h) The Employee shall keep and maintain (or cause to be kept and maintained) appropriate records, consistent with prevailing standards of
medical practice in the Employee’s relevant community, relating to all professional services rendered by the Employee under this Agreement and shall prepare and attend to, in connection with such services, all reports, claims, and
correspondence necessary or appropriate in the circumstances, as determined solely by the Company, all of which records, reports, claims, and correspondence shall belong to the Company. 
  
 20. Non-Competition and Non-Solicitation Agreement. 
  
 (a) The Employee acknowledges that during the course of the
Employee’s employment the Employee has and will receive confidential and proprietary information from and concerning the Company. The Employee also acknowledges that the Company has made and/or will make substantial investments in the further
development of the Company’s goodwill and in the Employee’s professional development. The capital expended to develop this goodwill directly benefits the Employee and should continue to do so in the event that the relationship between the
Company and the Employee is terminated. Likewise, other capital investments made or to be made by the Company to assist in the Employee’s professional development (including but not limited to those items listed below) have conferred and will
confer a direct economic benefit on the Employee. During the course of the Employee’s tenure with the Company, the Employee will have received the following economic benefits as a result of capital expenditures by the Company: 
  
 (1) Placement in an ongoing practice of pathology with an
established revenue base. 
  
 (2) The opportunity
to establish a professional relationship among clients served by the Company and its affiliates. 
  
 (3) Marketing support enabling the Employee to expand the Employee’s own pathology practice and to become known by additional
clients. 
  
 (4) The provision of contract
management to enable the Employee to obtain provider status in managed care plans. 
  

 - 12 - 

 (5) The opportunity to develop special areas of expertise leading to requests for
consultations on specific areas of pathology practice. 
  
 (6) The establishment of methodologies, practice parameters and quality assurance programs to enhance the Employee’s practice of pathology. 
  
 (7) The development and implementation of information systems and reporting formats, unique to the practice of pathology, to make the
provision of pathology services more efficient, and to maximize the time available to the Employee for the performance of pathology (as opposed to attending to administrative functions). 
  
 (8) Financial support and practice coverage to facilitate participation in continuing education
opportunities. 
  
 (9) Financial support and
practice coverage enabling the Employee to pursue additional board certifications. 
  
 (10) Financial support and practice coverage to participate in professional development and professional associations. 
  
 (11) Participation in proprietary strategic planning
sessions which focus on professional and business aspects of the practice of pathology and growth opportunities. 
  
 The Employee agrees that the Company and that the Company is entitled to protect these business interests and investments and to prevent the Employee from
using or taking advantage of the foregoing economic benefits to the Company’s detriment. 
  
 (b) Accordingly, the Employee specifically agrees that, except for the services and duties that the Employee performs for or on behalf of
the Company pursuant to the terms of this Agreement, during the Employee’s employment with the Company and during the Restricted Period (as defined in Subsection (c) below), the Employee shall not, as a shareholder, principal, agent,
consultant, manager, advisor, director, officer, control person, operator, or in any other capacity or manner whatsoever, engage in the practice of pathology at, with or for any medical facility, laboratory or healthcare provider in which the
Company, AmeriPath, or any Affiliate of the Company or AmeriPath, is then doing business or providing services or has done business or provided service within the preceding twelve (12) month period or for which the Company, AmeriPath, or any
Affiliate of the Company or AmeriPath, is actively negotiating to provide services. 
  
 (c) As used in this Agreement, the term “Restricted Period” shall mean and include the period during which the Employee
is Employed by the Company, or any Affiliate of the Company and a period of one (1) year from the effective date of the Employee’s termination 

  

 - 13 - 

 
of employment with the Company or such Affiliate of the Company (regardless of the cause, reason or justification of any such termination); provided,
however, 
  
 (i) in the event of a termination of
Employee’s employment hereunder without “cause” pursuant to Sections 15(c) and 15(d) hereof, if the Company fails to make payment of the amount(s) required to be paid under Section 15(c) hereof, and such failure shall continue uncured
for a period of more than sixty (60) days following notice from the Employee, then the Restricted Period shall be reduced to a period of zero (0) days; or 
  
 (ii) in the event AmeriPath fails to (1) pay any salary due the employee when such becomes due and payable or (2) materially comply with
the terms and conditions of the Purchase Agreement and such failure shall continue uncured for a period of more than sixty (60) days following notice from the Employee, then the Restricted Period shall be reduced to a period of zero (0) days.

  
 (d) The Employee further agrees that during
the Restricted Period the Employee will not, directly or indirectly, (1) solicit the employment of any employee, agent or consultant of the Company, or an Affiliate of the Company, who was such at any time during the twelve (12) months preceding the
Employee’s termination of employment with the Company, or (2) induce any employee of the Company, or any Affiliate of the Company, to leave the employ of the Company (or of such Affiliate), or (3) solicit any payor contracts from any payor of
the Company (or of an Affiliate of the Company), or otherwise interfere with any such payor, or (4) solicit or otherwise interfere with any referral sources of the Company or any Affiliate of the Company, unless in each case the Employee obtains the
prior written consent of the Company. 
  
 (e) In
recognition of the substantial nature of such potential damages, the Employee agrees that the Company shall be entitled to specific performance of this provision, and to injunctive and other equitable relief, and that the Employee will be
responsible for the payment of court costs and reasonable attorneys’ fees incurred by the Company in seeking enforcement the covenant set forth herein. This Section 20 shall survive the termination of this Agreement and the termination of the
Employee’s employment with the Company. The Employee acknowledges that the enforcement of this covenant is not contrary to the public health, safety, or welfare in that the population in the areas set forth herein is adequately served by
qualified pathologists. Further, the Employee acknowledges that the Employee’s breach of this covenant will cause irreparable injury to the Company. 
  
 21. Confidentiality. 
  
 (a) Acknowledgement. The Employee acknowledges and agrees that in the course of rendering services to the Company and its clients,
the Employee will have access to and will become acquainted with confidential and proprietary information about the professional, business and financial affairs of the Company, its Affiliates and its patients, clients and customers, and that 

  

 - 14 - 

 
the Employee may have contributed to or may in the future contribute to such information. The Employee further recognizes that the Employee is being employed
as a key employee, that the Company is engaged in a highly competitive business, and that the success of the Company in the marketplace and business depends upon its goodwill and reputation for integrity, quality and dependability. The Employee
recognizes that in order to guard the legitimate interests of the Company it is necessary for the Company to protect all such confidential and proprietary information, goodwill and reputation. 
  
 (b) Proprietary Information. In the course of the
Employee’s service to the Company, the Employee may have access to confidential know-how, business documents or information, marketing data, client lists and trade secrets which are confidential. Such information shall hereinafter be called
“Proprietary Information” and shall include any and all items enumerated in the preceding sentence which come within the scope of the business activities of the Company as to which the Employee has had or may have access, whether
previously existing, now existing or arising hereafter, whether or not conceived or developed by others or by the Employee alone or with others during the period of his service to the Company, and whether or not conceived or developed during regular
working hours. “Proprietary Information” shall not include (a) any information which is in the public domain during the period of service by the Employee or becomes public thereafter, provided such information is not in the public domain
as a consequence of disclosure by the Employee in violation of this Agreement, and (b) any information not considered confidential information by similar enterprises operating in the clinical or anatomical laboratory industry or otherwise in the
ordinary course. 
  
 (c) Fiduciary
Obligations. The Employee agrees and acknowledges that the Proprietary Information is of critical importance to the Company and a violation of this Section 21 will seriously and irreparably impair and damage the Company’s businesses. The
Employee therefore agrees, while he is an employee of the Company and at all times thereafter, to keep all Proprietary Information strictly confidential. 
  
 (d) Non-Disclosure. Except as required by law or order of any court or governmental entity or in connection with the proper
performance of his duties hereunder, the Employee shall not disclose, directly or indirectly (except as required by law), any Proprietary Information to any person other than (a) the Company, (b) persons who are authorized employees of the Company
at the time of such disclosure, (c) such other persons, including prospective investors or lenders, to whom the Employee has been instructed to make disclosure by the Company’s Board of Directors, or (d) the Employee’s counsel, which
counsel shall keep all Proprietary Information confidential (in the case of clauses (b) and (c), only to the extent required in the course of the Employee’s service to the Company). Upon any termination of the Employee’s employment
hereunder, the Employee shall deliver to the Company all notes, letters, documents, tapes, discs, recorded data and records which may contain Proprietary Information which are then in the Employee’s possession or control and shall not retain,
use, or make any copies, summaries or extracts thereof. 
  

 - 15 - 

 22. Invalid Provision. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement. The Employee and the Company agree and acknowledge that the provisions of Sections 20 and 21 are material and of the essence to this Agreement. If
the scope of any restriction or covenant contained herein should be or become too broad or extensive to permit enforcement thereof to its fullest extent, then such restriction or covenant shall be enforced to the maximum extent permitted by law, and
the Employee hereby consents and agrees that (a) it is the parties intention and agreement that the covenants and restrictions contained herein be enforced as written, and (b) in the event a court of competent jurisdiction should determine that any
restriction or covenant contained herein is too broad or extensive to permit enforcement thereof to its fullest extent, the scope of any such restriction or covenant may be modified accordingly in any judicial proceeding brought to enforce such
restriction or covenant, but should be modified to permit enforcement of the restrictions and covenants contained herein to the maximum extent the court, in its judgment, will permit. 
  
 23. Applicable Law. This Agreement shall be governed by and
construed and enforced in accordance with the laws of the State of Texas. 
  
 24. Binding Effect; Assignment. This Agreement shall inure to the benefit of and be binding on the Employee and the Company and the Employee’s and the Company’s respective heirs, personal
representatives, successors and assigns; however, that the Employee shall have no right to assign the Employee’s rights or duties under this contract to any other person. In the event of the Company’s sale, merger or consolidation,
the Employee specifically agrees that the Company may assign the Company’s rights and obligations hereunder to the Company’s successor, assign or purchaser. In addition, and in any event, the Company may, at any time, assign the
Company’s rights and obligations under this Agreement to any Person that is an Affiliate of the Company or to any Person which, after any such assignment, employs at least 50% of the physician employees employed by the Company immediately prior
to the assignment, provided, that any successor shall expressly assume, and AmeriPath, Inc. (the Company’s parent), or its successor, shall guaranty, the obligations hereunder. 
  
 25. Notices. Any required notice under this Agreement shall be
made and delivered in writing. Delivery of such notice shall be made (x) if to the Company, to AmeriPath, Inc., 7289 Garden Road, Suite 200, Riviera Beach, Florida 33404, Attention: President; and (y) if to the Employee, to the last known
residential address of Employee as listed in the Company’s employment records with a copy to Thompson & Knight, 1700 Pacific Avenue, Suite 3300, Dallas, Texas 75201-4693, Attention: Steven Cochran. Delivery of such notice shall be deemed to
have occurred (i) in the case of hand delivery, when personally delivered to the other party at such party’s address; or (ii) in the case of mailing, three (3) days after such notice has been deposited in the United States mails, postage
prepaid, by certified or registered mail, with return receipt requested, and addressed to the other party as set forth in this Agreement; or (iii) in any other case, when actually received by the other party. Either party may change the address to
which notices are to be given by giving written notice of such change to the other party in accordance with this Section 25. 
  

 - 16 - 

 26. Attorneys’ Fees and Costs. In any action, suit or proceeding to enforce the terms
and conditions of this Agreement, the prevailing party shall receive and the unsuccessful party shall pay all costs, fees and expenses, including reasonable attorney’s costs, fees and expenses, incurred in enforcing its rights under this
Agreement, including costs, expenses and fees with respect to trials, appeals and collection. 
  
 27. Amendment. This Agreement may not be modified or amended in any manner other than in a written document signed by both parties.

  
 28. Legislative Limitations. Notwithstanding any
other provision of this Agreement, if the governmental agencies (or their representatives) which administer Medicare or Medicaid, or any other government third party payor program, or any other federal, state or local government or agency passes,
issues or promulgates any law, rule, regulation, standard or interpretation at any time while this Agreement is in effect which prohibits, restricts, limits or in any way adversely changes the method or amount of reimbursement, compensation or
payment for services rendered by the Company (or its physician employees) under this Agreement, or which otherwise adversely affects either the Employee’s or the Company’s rights or obligations hereunder, then (i) the parties hereto shall,
promptly upon notice from either party, negotiate in good faith to amend this Agreement to provide for such reimbursement, compensation or payment for services in a manner consistent with any prohibition, restriction, limitation and/or which takes
into account any adverse change in reimbursement, compensation or payment for physician services, and (ii) in the event the parties are unable to reach agreement within ten (10) days after said notice is given, the Company shall assign this
Agreement (and the Company’s rights and obligations hereunder) to an Affiliate, so long as (1) such Affiliate is of equal or greater financial strength as the Company or (2) the Company guarantees the obligations of such Affiliate hereunder (if
such assignment cures or substantially alleviates such prohibition, restriction, limitation or adverse change). 
  
 29. Miscellaneous. 
  
 (a) Exclusive Agreement. The terms of the Employee’s employment with the Company are exclusively governed by the terms of this
Agreement. Any and all prior agreements, arrangements, promises, representations, discussions or understandings which either of the parties may have had concerning the Employee’s employment are hereby canceled, superseded and of no further
force or effect. 
  
 (b) Confidentiality.
The Company and the Employee acknowledge and agree that this Agreement and each of the provisions hereof shall be treated as confidential and, except to the extent required by applicable law or regulations or order of any court or governmental
entity, or as deemed reasonably necessary by the Company to facilitate due diligence in connection with acquisitions or financings, neither the Employee nor the Company shall disclose the terms of the Agreement, or provide copies hereof, to any
third party (other than counsel or advisers) without the prior written consent of the other party. 
  

 - 17 - 

 (c) Definitions. (1) “Affiliate” shall mean and include, with
regard to any Person, (a) any Person, directly or indirectly, controlled by, under common control of, or controlling such Person, (b) any Person, directly or indirectly, in which such Person holds, of record or beneficially, five percent or more of
the equity or voting securities, (c) any Person that holds, of record or beneficially, five percent or more of the equity or voting securities of such Person, (d) any Person that, through Contract, relationship or otherwise, exerts a substantial
influence on the management of such Person’s affairs, (e) any Person that, through Contract, relationship or otherwise, is influenced substantially in the management of their affairs by such Person, or (f) any director, officer, partner or
individual holding a similar position in respect of such Person. 
  
 (2) “Company” Where a provision contained in this Agreement requires or permits the action, adoption, review or approval of, or provides for certain power, authority or judgment of, the Company, such
action, adoption, review, approval, power, authority or judgment may be exercised, taken or made by an Affiliate of the Company, or by AmeriPath or its Affiliates, if such Affiliate of the Company, or AmeriPath or its Affiliates, is required or
permitted to exercise, take or make such action, adoption, review, approval, power, authority or judgment through or by virtue of a Contract to which the Company or the Employee is a party or otherwise. 
  
 (3) “Contract” means and includes any
agreement, contract, commitment, instrument or other binding arrangement, obligation or understanding, whether written or oral. 
  
 (4) “Person” means and includes any corporation, partnership, joint venture, company, syndicate, organization,
association, trust, entity, authority or natural person. 
  
 (d) Consent to Jurisdiction; Service of Process. The Employee hereby irrevocably submits to the jurisdiction of the state or federal courts wherein lies the Company’s main office (in greater metropolitan
Dallas, Texas) in connection with any suit, action or other proceeding arising out of or relating to this Agreement and hereby agrees not to assert, by way of motion, as a defense, or otherwise in any such suit, action or proceeding that the suit,
action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced by such courts. 
  
 (e) Headings. The article, section and other headings
contained in this Agreement are for reference purposes only and do not affect in any way the meaning or interpretation of any or all of the provisions of this Agreement. 
  

 - 18 - 

 (f) Pronouns and Plurals. Whenever the context may require, any pronoun used in
this Agreement shall include the corresponding masculine, feminine, or neuter forms, and the singular forms of nouns, pronouns, and verbs include the plural and vice versa. 
  
 (g) Construction. The parties acknowledge that each party has reviewed and revised this Agreement and
that the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. 
  
 (h) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. 
  
 * * * * 
  
 [Remainder of Page
Intentionally Left Blank] 
  

 - 19 - 

 IN WITNESS WHEREOF, the parties hereto have made and entered into this Agreement as of the date
first hereinabove set forth. 
  

			
	AMERIPATH DALLAS
		
	 By:
	 	/s/ Robert P. Wynn
	 	 	Robert P. Wynn, Vice President
	
	EMPLOYEE:
	
	/s/ Stephen W. Aldred
	STEPHEN W. ALDRED, M.D.

  

 - 20 - 

  
 ANNEX A 
  
 Baylor/Richardson Medical Center 
 RHD Memorial Medical Center 
 Trinity Medical
Center 
 Columbia Medical Center at Terrell 
 Mary Shiels Hospital 
 Park Central Surgery Center 
 Valley View Surgery Center 
 Quest Laboratories 
 Columbia Medical Center at Plano 
 Laboratory
Corporation of America 
 Columbia Navarro Regional Hospital 
 Memorial Mother Francis 
 Columbia North Hills Hospital 
 Columbia Medical Center of Arlington

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]